Dr John R Brouillette, MD | |
35 W Lakeshore Dr, Homewood, AL 35209-7253 | |
(205) 226-5900 | |
(205) 226-5937 |
Full Name | Dr John R Brouillette |
---|---|
Gender | Male |
Speciality | Nephrology |
Experience | 31 Years |
Location | 35 W Lakeshore Dr, Homewood, Alabama |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821056318 | NPI | - | NPPES |
000007964 | Medicaid | AL |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RN0300X | Internal Medicine - Nephrology | 18202 (Alabama) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Fmc Forestdale | Birmingham, AL | Dialysis facility |
Rcg Oneonta | Oneonta, AL | Dialysis facility |
Shelby Baptist Medical Center | Alabaster, AL | Hospital |
Brookwood Baptist Medical Center | Birmingham, AL | Hospital |
St Vincents Blount | Oneonta, AL | Hospital |
St Vincent's Birmingham | Birmingham, AL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nephrology Associates, Pc | 1557330859 | 28 |
News Archive
China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.
In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).
Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.
Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.
› Verified 9 days ago
Entity Name | Nephrology Associates, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023030152 PECOS PAC ID: 1557330859 Enrollment ID: O20041001000790 |
News Archive
China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.
In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).
Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.
Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.
› Verified 9 days ago
Entity Name | Fresenius Vascular Care Birmingham Mso Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710766829 PECOS PAC ID: 9537419890 Enrollment ID: O20240220002651 |
News Archive
China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.
In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).
Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.
Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr John R Brouillette, MD 35 W Lakeshore Dr, Homewood, AL 35209-7253 Ph: (205) 226-5900 | Dr John R Brouillette, MD 35 W Lakeshore Dr, Homewood, AL 35209-7253 Ph: (205) 226-5900 |
News Archive
China Jo-Jo Drugstores, Inc., which operates retail pharmacies in the People's Republic of China, today reported financial results for the second quarter and six month period of fiscal 2011 ended September 30, 2010.
In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that data from a Phase II study from Brown University of OPAXIO(TM) (paclitaxel poliglumex) combined with standard cisplatin and concurrent radiation in patients with advanced esophageal cancer will be presented by Dr. Howard Safran in an oral Proffered Papers session at the Annual Meeting of the International Society of Gastrointestinal Oncology in Philadelphia, Pennsylvania on Thursday, October 1st at 2:35 p.m. (Eastern time).
Silence Therapeutics plc, a leading global RNA interference therapeutics company, announces that it will present new data from its ongoing Phase I study of Atu027, its lead internal therapeutic candidate, at the 2011 American Society of Clinical Oncology Annual Meeting on 06 June 2011.
Long believed to be a disease of biblical times, leprosy, also known as Hansen's disease, continues to be seen in the United States.
› Verified 9 days ago
Dr. Jeffrey H Glaze, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 35 W Lakeshore Dr, Homewood, AL 35209 Phone: 205-226-5900 Fax: 205-226-5937 | |
Emily Dolbare Feely, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2700 Rodgers Drive, Suite 102, Homewood, AL 35209 Phone: 205-226-5900 Fax: 205-226-5937 | |
William Lyndon, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 35 W Lakeshore Dr, Homewood, AL 35209 Phone: 205-226-5900 Fax: 205-226-5937 | |
Dr. Oksana Senyk, M.D., PH.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2045 Brookwood Medical Ctr Dr Ste 1, Homewood, AL 35209 Phone: 205-978-0550 Fax: 205-978-0085 | |
Agata Przekwas, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 35 W Lakeshore Dr, Homewood, AL 35209 Phone: 205-226-5900 Fax: 205-226-5937 | |
Mitchel Scott Touger, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 300 Royal Tower Dr, Homewood, AL 35209 Phone: 205-874-1958 Fax: 205-874-1943 | |
Joelle P Hamilton, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3485 Independence Drive, Homewood, AL 35209 Phone: 205-930-0920 Fax: 205-445-0115 |